NCT02443545 Long-term Safety and Efficacy of Ferriprox® in Iron Overloaded Patients With Sickle Cell Disease or Other Anemias Status TERMINATED Phase PHASE4
NCT02435901 HSCT For Patients With High Risk Hemoglobinopathies Using Reduced Intensity Status COMPLETED Phase PHASE1/PHASE2
NCT02433158 Safety of Rivipansel (GMI-1070) in the Treatment of One or More Vaso-Occlusive Crises in Hospitalized Subjects With Sickle Cell Disease Status TERMINATED Phase PHASE3
NCT02411396 Comparison of Patient Centered Outcomes for People With Sickle Cell Disease in the Acute Care Setting Status COMPLETED Phase N/A
NCT02410811 Novel Cardiac Magnetic Resonance Imaging to Define a Unique Restrictive Cardiomyopathy in Sickle Cell Disease Status COMPLETED Phase N/A
NCT02394899 Improving Parental Psychosocial Functioning and Early Developmental Outcomes in Children With Sickle Cell Disease Status COMPLETED Phase NA
NCT02394431 Added Value of Speckle Tracking in the Evaluation of Patients With Sickle Cell Disease Status COMPLETED Phase N/A
NCT02386657 Single-center Prospective Evaluation of Sickle Cell Patient Care in the CHU Brugmann Emergency Department Status COMPLETED Phase N/A
NCT02384590 Cognitive Behavioral Therapy and Real-time Self-management Intervention for SCD Via Mobile Applications Status COMPLETED Phase NA
NCT02371720 Patient Centered Comprehensive Medication Adherence Management System in Patients With Sickle Cell Disease Status COMPLETED Phase NA
NCT02314689 A Dose Escalation Study of Intravenous L-citrulline in Steady-state Sickle Cell Disease Status COMPLETED Phase PHASE1
NCT02285088 A Study of the Safety, Blood Levels and Biological Effects of GBT440 in Healthy Subjects and Subjects With Sickle Cell Disease Status COMPLETED Phase PHASE1
NCT02273310 Families Taking Control (FTC): Family-based Problem-solving Intervention for Children With Sickle Cell Disease Status COMPLETED Phase NA
NCT02261480 A New Reagent Assay Examining Natural Parvovirus B19 Infection in Sickle Cell Disease Status COMPLETED Phase N/A